DBS-based Biomarkers of Neurodegeneration predict Cognitive Decline and Dementia Seven Years Ahead in a Large Population-Based Sample

DBS-based biomarkers of neurodegeneration provide a cost-efficient and scalable early warning signal enabling preventive measures against AD/ADRD before the onset of serious symptoms.